BSW Wealth Partners Sells 678 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

BSW Wealth Partners cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 43.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 878 shares of the medical equipment provider's stock after selling 678 shares during the period. BSW Wealth Partners' holdings in Intuitive Surgical were worth $435,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ISRG. Onefund LLC lifted its position in Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock valued at $494,000 after purchasing an additional 18 shares during the last quarter. AlphaCore Capital LLC increased its stake in shares of Intuitive Surgical by 4.2% in the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after buying an additional 18 shares during the period. Parkside Financial Bank & Trust raised its holdings in Intuitive Surgical by 2.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 747 shares of the medical equipment provider's stock valued at $390,000 after buying an additional 19 shares during the last quarter. Accredited Investors Inc. boosted its position in Intuitive Surgical by 1.9% during the 4th quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider's stock valued at $543,000 after buying an additional 19 shares during the period. Finally, Second Line Capital LLC boosted its position in Intuitive Surgical by 3.4% during the 4th quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock valued at $302,000 after buying an additional 19 shares during the period. 83.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

ISRG has been the topic of a number of analyst reports. BTIG Research set a $560.00 price objective on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Piper Sandler reduced their price target on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Truist Financial dropped their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Barclays cut their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Finally, Evercore ISI decreased their target price on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a report on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $588.95.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of the company's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president now owns 907 shares of the company's stock, valued at $510,740.77. This represents a 19.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the transaction, the executive vice president now directly owns 2,245 shares in the company, valued at approximately $1,152,089.10. The trade was a 43.09% decrease in their position. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock worth $2,611,577 over the last three months. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Trading Up 1.2%

ISRG stock traded up $6.29 during midday trading on Monday, hitting $540.00. The company's stock had a trading volume of 179,115 shares, compared to its average volume of 1,988,157. The company has a market cap of $193.55 billion, a PE ratio of 79.22, a P/E/G ratio of 5.66 and a beta of 1.67. The firm's 50-day moving average is $532.08 and its 200-day moving average is $536.70. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same period last year, the firm posted $1.50 earnings per share. Analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.